Public-registry site landscape for NCT03555422, a Endometrial Cancer study sponsored by Karyopharm Therapeutics Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03555422 (registry record) |
| Sponsor | Karyopharm Therapeutics Inc |
| Condition(s) | Endometrial Cancer |
| Phase | PHASE3 |
| Listed sites | 78 |
| Site countries | United States, Belgium, Canada, China, Czechia, Germany, Greece, Israel, Italy, Spain |
Eichor generates a preliminary site-risk snapshot for NCT03555422 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →